REFERENCES
- Mercer T. T. Production and characterisation of aerosols. Arch. Intern. Med. 1973; 131(1)39–50
- Clarke S. Inhaler therapy. Q. J. Med. 1988; 67(253)355–368, New Series
- Kane J., Sternheim M. Les ultrasons. Physique. Inter éditions, Paris 1986; 510, chap. 22
- Stahlhofen W., Gebhart J., Heyder J., Scheuch G. Deposition pattern of droplets from medical nebulizers in the human respiratory tract. Bull. Eur. Physiopath. Resp. 1983; 19: 459–463
- Boguslavskii. Cavitation. Ultrasonics: Fundamentals and Applications, H. Kuttruff. Elsevier Applied Science, New Elsevier Applied Science, New York 1995; 363–394
- Guichard J. C. Les générateurs d'aérosols médicamenteux. Poumon. 1979; 35: 327–335
- Lourenco R. V., Cotromanes E. Clinical aerosols I. Characterisation of aerosols and their diagnostic uses. Arch. Intern. Med. 1992; 142: 2163–2172
- O'Doherty M. J., Miller R. F. Aerosols for therapy and diagnosis. Eur. J. Nuclear Med. 1993; 20(12)1201–1213
- Flament M. P., Leterme P., Burnouf T., Gayot A. T. Jet nebulization: influence of dynamic conditions and nebulizers on nebulization quality. Application to the α1 protease inhibitor. Int. J. Pharm. 1997; 148: 93–101
- Le Brun P. P.H., De Boer A. H., Gjaltema D., Hagedoorn P., Heijerman H. G.M., Frijlink H. W. Inhalation of tobramycin in cystic fibrosis. Part 1: The choice of a nebulizer. Int. J. Pharm. 1999; 189: 205–214
- Taylor K. M.G., Hoare C. Ultrasonic nebulization of pentamidine isethionate. Int. J. Pharm. 1993; 98: 45–49
- Cipolla D. C., Clarck A. R., Chan H. K., Gonda I., Shire S. J. Assessments of aerosol delivery systems for recombinant human deoxyribonuclease. STP Pharma Sci. 1994; 4: 50–62
- Ip A. Y., Arakoawa T., Silvers H., Ransone C. M., Nive R. W. Stability of recombinant consensus interferon to air-jet and ultrasonic nebulization. J. Pharm. Sci. 1995; 84: 1210–1214